Manar Abdalgani
Allergy & Immunology · New York, NYNPI 1154671873
Payments from drug & device makers
Across 63 payments — averaging $180.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$8K
- Amgen$2K
- AstraZeneca$470
- Grifols USA, LLC$304
- Sanofi$234
- Takeda Pharmaceuticals U.S.A., Inc.$91
- plus $175 from 5 others
What the payments were for
- Consulting fees$5,89652%
- Speaking & faculty fees$2,00018%
- Travel & lodging$1,75715%
- Food & beverage$1,69415%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 7 | $7,986 |
| Amgen(2 entities) | 5 | $2,088 |
| AstraZeneca | 19 | $470 |
| Grifols USA, LLC | 15 | $304 |
| Sanofi | 5 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Novartis | 3 | $56 |
| Pharming Healthcare, Inc. | 2 | $49 |
| GSK | 1 | $31 |
| CSL Behring | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIMMUNE$2,000
How this compares
$11,348 in reported general payments places this provider in the 70th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 17 | $391 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $354 |
| Fluticasone Propionate | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in New York
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$980K
- Paula BusseNew York$821K
- Richard InselNew York$269K
- Joyce YuNew York$209K
- Arthur LubitzNew York$196K
- Purvi ParikhNew York$196K
- Charlotte Cunningham-RundlesNew York$180K
- Ama AlexisNew York$120K
- Zoya TreysterNew York$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.